Take a look behind the scenes of a recent Future Virology article, entitled ‘Update on HIV integrase inhibitors for the treatment of HIV’, as we ask the authors about these drugs for HIV treatment and the future of this field.
Researchers have discovered an association between the spread of HIV and quantity of extracellular vesicles from lactobacilli, suggesting a protective mechanism to inhibit the spread of HIV infection.
In this interview, we speak to Jenn Edwards from the Abigail Wexner Research Institute (OH, USA) about her research using the primary human epithelial cell models to examine Neisseria gonorrhoeae infections, the potential for vaccination against gonorrhea and a possible host-targeted therapy for this infection.
The WHO have updated their recommendations on HIV testing in order to try and expand treatment coverage and reach the people living with HIV who are not yet diagnosed.
Results from a new survey of young adults has suggested a poor knowledge of HIV transmission, persisting stigma around living with HIV and high-risk sexual behaviours.
Research presented at IDWeek has discovered that users of the social networking app, Grindr, took more risks and had more partners but were more likely to use, or be open to using, PrEP compared with those who didn’t use the app.
The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
Find out more about the headlines from the 10th International AIDS Society Conference on HIV Science (IAS 2019) in our round-up of conference news.
A new study using CRISPR-Cas9 and long-acting slow-effective release antiretroviral therapy has reported the elimination of replication-competent HIV-1 DNA from the genomes of living animals for the first time.
A report analyzing the prevalence and incidence of chlamydia, gonorrhea, trichomoniasis and syphilis for 2016 has reported that rates of these four curable sexually transmitted infections remain high, estimating 376.4 million cases in 2016.
